Development of glucose-responsive hydrogels based upon genetically engineered glucose binding protein dimer (GBPd)

CHED 817

Peter J. Rosado, peterjosue@gmail.com1, Kendrick B. Turner, kendrick.turner@uky.edu2, Elissavet Moschou, l_moschou@yahoo.com2, and Sylvia Daunert, daunert@uky.edu2. (1) Department of Chemistry, Interamerican University of Puerto Rico, San German Campus, San German, PR 00683, (2) Department of Chemistry, University of Kentucky, Lexington, KY 40506
Many periplasmic binding proteins in bacteria undergo conformational changes in response to the presence of a target analyte and thus act as stimuli-responsive molecular machines. In this work, the development of glucose-sensitive hydrogels was pursued by the integration of a dimer of the glucose binding protein (GBPd) within a polyacrylamide hydrogel network. The integration of GBPd within the hydrogel causes a change in the volume of the hydrogel in response to glucose. The presence of glucose should result in a shrunken hydrogel while removal of glucose should result in a swollen hydrogel. This has been shown previously using the monomer of GBP, however greater response is expected when using the dimer. To that end, GBPd was expressed, purified, and integrated into the hydrogel material. Preliminary results suggest the extent of cross-linking within the hydrogel should be reduced to allow for volume changes in the material upon analyte binding. Glucose-responsive hydrogels should find applications in high-throughput screening, responsive drug delivery, as well as in a variety of microfluidic systems and bioMEMS devices.